Helio Genomics, Inc., a commercial-stage AI-powered precision liver diagnostics company focused on improving outcomes for at-risk patients through early cancer detection, disease surveillance, and ...

The global multiomics market, valued at $3.41 billion in 2025, is forecast to reach $12.82 billion by 2036, growing at a 13.31% CAGR from 2026 to 2036. Growth is driven by precision medicine, ...

OmicsBox 4.0 adds cloud integration, advanced transcriptomics tools like gene co-expression, and AI-powered summaries ...

Genomics tools—fine-tuned and applied to agriculture—create commercially desirable traits in a fraction of the time required ...

GPT-5.6 Sol Pro disproved a 20-year-old statistics conjecture in 90 minutes that GPT-5.5 couldn't crack in over 20 hours — a ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

IRC §41(b)(2)(A)(iii) allows businesses to count amounts paid for the right to use computers in qualified research as ...

Dow Jones futures: Taiwan Semiconductor and GE Aero fell despite strong earnings as the AI stock sell-off continues.

Bionano Genomics, Inc. (NASDAQ: BNGO), a leader in genome analysis solutions, today announced the appointment of Alex Hastie, Ph.D. , as its Chief Scientific Officer (CSO) , effective July 20, 2026.

Illumina dominates genomics sequencing with recurring growth, NovaSeq X catalysts, and improving margins/FCF. Click to know ...

A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high cholesterol to a rare muscular disorder ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics (ESHG) conference grew substantially compared ...